Leuprolide acetate and central retinal vein occlusion

Ophthalmic Surgery Lasers and Imaging

Volumn 38, Issue 6, 2007, Pages 497-499

  Federici, Thomas J ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUINDOSTATIN; LEUPRORELIN; LISINOPRIL; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; CLINICAL FEATURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; VISUAL ACUITY; CHEMICALLY INDUCED DISORDER; FLUORESCENCE ANGIOGRAPHY; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PROSTATE TUMOR; RETINA VEIN OCCLUSION;

ANTINEOPLASTIC AGENTS, HORMONAL; FLUORESCEIN ANGIOGRAPHY; HUMANS; LEUPROLIDE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 38349044159     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20071101-09     Document Type: Article

References (6)

1. The Leuprolide Study Group. Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med. 1984;311:1281-1286.
2. Bern MM. Coagulopathy, following medical therapy, for carcinoma of the prostate. Hematology. 2005;10:65-68.
3. Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: The Blue Mountains Eye Study. Arch Ophthalmol. 2006;124:726-732.
4. Lahey JM, Tunç M, Kearney J, et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology. 2002;109:126-131.
5. Kirwan JF, Tsaloumas MD, Vinall H, Prior P, Kritzinger EE, Dodson PM. Sex hormone preparations and retinal vein occlusion. Eye. 1997;11:53-56.
6. Reddy A, Edesten C, Hardman-Lea S. A transsexual patient with bilateral central retinal vein occlusions. Eye. 2000;14:104-105.